Uniphar (LON:UPR) Trading 1.5% Higher – Still a Buy?

Uniphar plc (LON:UPR) shares were up 1.5% during trading on Tuesday . The stock traded as high as GBX 342.95 ($4.61) and last traded at GBX 340 ($4.57). Approximately 54,122 shares were traded during trading, an increase of 9% from the average daily volume of 49,657 shares. The stock had previously closed at GBX 335 ($4.50).

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UPR. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 375 price target on shares of Uniphar in a research note on Wednesday, July 30th. Royal Bank Of Canada lifted their price objective on Uniphar from GBX 470 to GBX 480 and gave the stock an “outperform” rating in a report on Tuesday, September 9th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of GBX 427.50.

Uniphar Trading Up 1.5%

The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The stock has a market capitalization of £882.55 million, a PE ratio of 1,387.76 and a beta of 0.75. The stock has a 50 day moving average price of GBX 341.28 and a 200-day moving average price of GBX 298.69.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.